Printer Friendly

PARTNERS DEBUT SENSOR HUB FOR WEARABLE HEALTH APPS.

imec and Holst Centre have debuted a new sensor hub integrated as a system-on-chip (SoC) intended for a broad range of wearable health devices and applications. The SoC combines an unprecedented number of biomedical analog interfaces into a single chip, on-board digital signal processing, high fidelity operation, and multi-day monitoring capability with a single battery. Thanks to its small form factor, the SoC can be easily integrated in new innovative designs enabling maximum user comfort. This new SoC is an enabler towards the transformation of today's mainly curative approach to healthcare to one that is preventative, predictive and personalized.

The biomedical analog interfaces include three ECG channels, photo-plethysmography (PPG), galvanic skin response (GSR), two multi-frequency bio-impedance (BIO-Z) channels to support new applications such as impedance- tomography, body fluid analysis and stroke volume measurements, and three reconfigurable channels.

While high performance multi-modal analog readouts have been demonstrated, they lack on-board signal processing capabilities, or are too large in size. Alternatively, existing reconfigurable readouts are smaller, but have limited performance. Imec's and Holst Centre's SoC moves beyond current solutions and combines advanced biomedical readouts, supported by an ARM Cortex M0+ controller and accelerators for sample-rate conversion, matrix processing, data compaction, and power management circuitry (PMIC). The PMIC operates from a battery source (2.9- 4.5V) and generates the required voltages for the readout IC. It supports dynamic voltage scaling optimized for, but not limited to, low power and high performance applications, and can be fully customized for specific healthcare applications.

There is a clear need for accurate and reliable bio- sensing in wearables, and we are working on the building blocks to enable this, stated Chris Van Hoof, program director wearable health at imec. Our new SoC sensor hub underscores patient-centric capabilities and can be integrated in numerous wearable fitness and healthcare applications such as patch monitors, chest band heart rate monitors, respiration or hydration monitors and devices for blood-pressure calculation.

Imec is a research hub in nano-electronics and digital technologies. The combination of our widely acclaimed leadership in microchip technology and profound software and ICT expertise is what makes us unique. By leveraging our world-class infrastructure and local and global ecosystem of partners across a multitude of industries, we create groundbreaking innovation in application domains such as healthcare, smart cities and mobility, logistics and manufacturing, and energy.

As a trusted partner for companies, start-ups and universities we bring together close to 3,500 brilliant minds from over 70 nationalities. Imec is headquartered in Leuven, Belgium and also has distributed R&D groups at a number of Flemish universities, in the Netherlands, Taiwan, USA, China, and offices in India and Japan. In 2015, imec's revenue (P&L) totaled 415 million euro and of iMinds which is integrated in imec as of September 21, 2016 52 million euro. For more information, visit www.imec.be.

About Holst Centre

Holst Centre is an independent R&D center that develops technologies for wireless autonomous sensor technologies and for flexible electronics, in an open innovation setting and in dedicated research trajectories. A key feature of Holst Centre is its partnership model with industry and academia based around shared roadmaps and programs. It is this kind of cross-fertilization that enables Holst Centre to tune its scientific strategy to industrial needs. Holst Centre was set up in 2005 by imec (Flanders, Belgium) and TNO (The Netherlands) and is supported by local, regional and national governments. Located on High Tech Campus Eindhoven, Holst Centre benefits from, and contributes to, the state-of-the-art on-site facilities.

For more information, visit www.havasformula.com or call 619/234-0345.
COPYRIGHT 2016 Worldwide Videotex
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2016 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Worldwide Biotech
Date:Nov 1, 2016
Words:596
Previous Article:FDA APPROVES ACCESS TO RECELL IN US BURNS TRIAL.
Next Article:APEIRON GRANTS EUSA PHARMA COMMERCIALIZATION RIGHTS.
Topics:

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters